- ASCO® 2024
- Yale Cancer Answers
- ASH CME Series
- Smilow Shares with Primary Care
- Grand Rounds
- Head and Neck
- Gynecologic
- Benign Hematology
- Breast
- GI
- Lung
- GU
- Hematologic Oncology
- Brain
- Cancer Screening
- DEI (Diversity, Equity and Inclusion)
- 2021 ASH Highlights
- General Events
- Events
Playback speed
10 seconds
Yale Updates on GBM & Meningioma: Are We Seeing Increased Survival Rates With TMZ + RT, Bevacizumab & New Optune Device Treatment? What Are the Meningioma Treatment Modalities?
By
Yale Cancer Center
FEATURING
Nicholas Blondin
By
Yale Cancer Center
FEATURING
Nicholas Blondin
89 views
February 3, 2021
Comments 0
Login to view comments.
Click here to Login
CNS